Drug use and responses in prison in Lithuania 2017

Lithuania Country Drug Report 2017

Drug use and responses in prison

The Lithuanian Prison Department manages the penal system, which accommodates more than 7 000 prisoners in its institutions. The available data indicate that the Lithuanian prison population rate is the highest in Europe. Around one in eight prisoners are reported to have mental and behavioural disorders as the result of narcotic or psychotropic substance use, according to International Classification of Diseases, 10th revision; however, the number of prisoners diagnosed as narcotic or psychotropic substance users has decreased since 2009. The majority of those diagnosed with mental and behavioural disorders in 2015 reported opioid use, although the use of multiple psychoactive substances was also common. A total of 256 HIV-positive prisoners had been reported by the end of 2015.

Medical services for prisoners are provided by healthcare services established in each prison and at the prison hospital. All prisons use repetitive criminal behaviour risk assessment methodologies to assess new prisoners, including the assessment of their psychoactive substance use behaviour.

Drug treatment activities in prisons are focused on the socio-psychological rehabilitation of dependent prisoners. Four prisons have residential rehabilitation centres and one prison has a day centre. In seven prisons, Alcoholics Anonymous and Narcotics Anonymous groups operate and follow the 12-step Minnesota Programme. OST is not available in Lithuanian prisons.

Free voluntary testing for infectious diseases is available in prisons, accompanied by some health education measures to reduce behaviours associated with a risk of contracting HIV, HBV and HCV.

Around one in eight prisoners in Lithuania have mental and behavioural disorders as the result of substance use


Lithuania main page
Loading